Typical CJC-1295 ipamorelin dosage in research ranges from 100–300 mcg of each peptide per injection, once or twice daily. Learn timing, blends, and safety.
Most research protocols put the CJC-1295 ipamorelin dosage between 100 mcg and 300 mcg of each peptide per injection, taken one to three times per day on an empty stomach, usually before bed. CJC-1295 and ipamorelin are both growth hormone secretagogues, so they are stacked to amplify the body's natural GH pulse rather than replace it. Neither peptide is FDA-approved for human use in the United States, and everything below describes research and community practice, not a prescription.
CJC-1295 Ipamorelin Dosage Chart for Research Use
The two peptides have very different half-lives, which is why each one is scheduled separately before they get combined into a single vial.
| Compound | Common research dose | Frequency | Notes |
|---|---|---|---|
| CJC-1295 without DAC (Mod GRF 1-29) | 100–200 mcg | 1–3x per day | Short half-life; mimics a natural GH pulse |
| CJC-1295 with DAC | 1–2 mg | 1–2x per week | Half-life of roughly 6–8 days |
| Ipamorelin | 100–300 mcg | 1–3x per day | Selective GH release with minimal impact on cortisol or appetite |
| Combined blend | 100–300 mcg of each | 1–2x per day | Typically fasted and pre-bed |
A common starting point in community logs is 100 mcg of each peptide once daily, moving toward 200–300 mcg of each only if side effects stay mild. Higher is not automatically better, because GH secretagogues tend to follow a bell-shaped response curve in animal models.
CJC-1295 and Ipamorelin Dosage Per Day and Timing
Timing matters as much as the number of micrograms. Both peptides work best when insulin and blood sugar are low, because eating blunts the GH pulse they are trying to trigger.
- Fasted: inject at least 2 hours after your last meal and wait 20–30 minutes before eating again.
- Pre-bed: the largest natural GH release happens during early deep sleep, so a bedtime dose lines up with the body's own rhythm.
- Frequency: one dose per day is the most common starting schedule, while some protocols use two or three smaller doses.
- Consistency: a fixed daily window matters more than chasing a perfect clock time.
People searching for cjc-1295 ipamorelin dosage per day in ml are usually asking about syringe units rather than micrograms. The volume depends entirely on how much bacteriostatic water was added to the vial, which is what the next section covers.
CJC-1295 Ipamorelin Blend Dosage Per Day by Vial Size
Blends arrive as a single vial containing both peptides, most often in a 5 mg + 5 mg format for 10 mg total. The cjc-1295/ipamorelin 10mg dosage is calculated from total peptide mass, so the same 200 mcg draw looks different depending on how much water you add.
| Blend vial | BAC water added | Concentration | 200 mcg draw (U-100 syringe) |
|---|---|---|---|
| 5 mg + 5 mg (10 mg) | 2 mL | 5 mg/mL | 4 units |
| 5 mg + 5 mg (10 mg) | 3 mL | 3.3 mg/mL | 6 units |
| 5 mg + 5 mg (10 mg) | 5 mL | 2 mg/mL | 10 units |
| 2 mg + 2 mg (4 mg) | 2 mL | 2 mg/mL | 10 units |
In a 5/5 blend, a 200 mcg draw delivers 100 mcg of CJC-1295 and 100 mcg of ipamorelin, because the two peptides are present in equal parts. A cjc-1295 no dac ipamorelin 10mg blend dosage follows the same math, while the DAC version simply needs far fewer injections per week.
The cjc-1295 ipamorelin blend dosage per day most people settle on is 200–300 mcg of the combined blend once or twice daily, which keeps each individual peptide inside the 100–150 mcg range per injection.
Dosing Protocol, Cycle Length, and Weekly Totals
Most self-reported cycles run 8 to 12 weeks followed by 4 weeks off, and many users choose a 5-days-on, 2-days-off pattern to reduce cost and injection fatigue.
- 200 mcg of each peptide twice daily, 5 days per week, equals roughly 2 mg of each peptide per week.
- 300 mcg of each peptide once daily, 7 days per week, equals roughly 2.1 mg of each peptide per week.
- Adding a CJC-1295 DAC dose of 1–2 mg per week raises total exposure well above that range.
Reported cjc 1295 ipamorelin peptide dosage ranges rarely exceed 300 mcg of each peptide per injection, and most logs stay under 10 mg of total peptide per week. Longer cycles are usually paired with periodic IGF-1 and fasting glucose labs rather than blind escalation.
Community threads such as ipamorelin/cjc 1295 dosage reddit are anecdotal by nature and often mix up micrograms, milligrams, and syringe units, so treat them as informal data points rather than a dosing standard.
Female Dosage and Weight Loss Claims
Women generally use the same 100–300 mcg per injection range as men, with some protocols starting at the lower end because body weight and lean mass are often lower. CJC-1295 and ipamorelin have not been studied in large randomized trials in either sex.
Some women ask about a cjc-1295 ipamorelin dosage calculator female users rely on, but most of these tools simply apply the same microgram range with a modest adjustment for body weight. They do not account for individual lab values, medical history, or medication interactions.
Weight loss is the claim that gets the most attention and has the least support. The only FDA-approved growth hormone–releasing peptide for fat reduction is tesamorelin, cleared for visceral fat in adults with HIV-associated lipodystrophy, and CJC-1295 with ipamorelin has no equivalent approval. Body composition changes reported in forums are self-reported and may reflect diet, training, sleep, or placebo effect.
Safety, Side Effects, and Legal Status
Commonly reported side effects in self-experimentation include water retention, tingling or numbness in the hands, headache, fatigue, injection site irritation, and elevated fasting glucose or IGF-1. Most are reversible after stopping, but persistent numbness deserves medical attention.
- Anyone with active cancer, uncontrolled diabetes, or pituitary disease should not use GH secretagogues without physician supervision.
- These peptides are not recommended during pregnancy or breastfeeding.
- They can interact with insulin, glucocorticoids, thyroid medication, and other hormone therapies.
- Vials sold online are labeled for research use only and are not verified for purity, sterility, or actual peptide content.
Talk with a healthcare professional before starting any peptide, and never use these compounds as a substitute for diagnosed conditions or prescribed treatment.
The Bottom Line
The typical CJC-1295 ipamorelin dosage in research settings is 100–300 mcg of each peptide, one to two times daily, injected fasted and often before bed. CJC-1295 and ipamorelin are not FDA-approved for human use in the United States. Screening, bloodwork, and medical oversight matter more than fine-tuning micrograms.
Frequently Asked Questions
How much CJC-1295 and ipamorelin should I take per day?
Most research and community protocols use 100–300 mcg of each peptide per injection, once or twice daily, with 200 mcg of each being a common middle ground. Doses are drawn from a reconstituted vial, so syringe units depend on how much bacteriostatic water you added. Neither peptide is FDA-approved for human use, and a healthcare professional should review any plan before you start.
What time of day should I inject CJC-1295 and ipamorelin?
Most protocols inject on an empty stomach at least two hours after the last meal, then wait 20–30 minutes before eating. The most popular window is 30–60 minutes before bed, because that aligns with the body's largest natural growth hormone pulse during early deep sleep. A second fasted dose in the morning is sometimes used.
Is a CJC-1295 ipamorelin 5/5 blend the same as a 10 mg blend?
A 5/5 blend contains 5 mg of CJC-1295 and 5 mg of ipamorelin, for 10 mg of total peptide, so it is the same product described two different ways. Dosing is based on micrograms of total peptide, not on the vial label alone. In a 5/5 blend, a 200 mcg draw gives 100 mcg of each peptide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.